ArticleCase reports in pediatrics2026
MOG Antibody-Associated Disease With Bilateral Deep Gray Matter Involvement in a Child: Unique MRI Findings and Therapeutic Response.
Article in Case reports in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MOG Antibody-Associated Disease With Bilateral Deep Gray Matter Involvement in a Child: Unique MRI Findings and Therapeutic Response.Case reports in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myelin oligodendrocyte glycoprotein antibody-associated disease is an autoimmune inflammatory demyelinating disorder of the central nervous system with diverse clinical and radiological manifestations; however, bilateral symmetric deep gray matter involvement is an exceptionally uncommon presentation in children. We report a previously healthy 3-year-old boy who presented with fever, encephalopathy, and focal seizures following a viral illness. Brain magnetic resonance imaging (MRI) demonstrated bilateral symmetric T2/FLAIR hyperintensities involving the basal ganglia, thalami, external capsules, subcortical white matter, and brainstem. Cerebrospinal fluid analysis revealed lymphocytic pleocytosis, and MOG-IgG antibodies were detected using a cell-based assay. Extensive infectious, metabolic, mitochondrial, and genetic investigations were unrevealing. Despite treatment with high-dose intravenous methylprednisolone and intravenous immunoglobulin, the patient showed minimal clinical improvement; however, six sessions of plasmapheresis resulted in marked neurological recovery, with complete clinical and radiological resolution by Day 24. This case expands the recognized neuroimaging spectrum of pediatric MOGAD and highlights the importance of considering MOGAD in children presenting with encephalopathy and atypical bilateral deep gray matter lesions after exclusion of alternative etiologies. It also underscores the potential role of plasmapheresis in severe or steroid-refractory cases, emphasizing the importance of early diagnosis and prompt immunomodulatory treatment for favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.